Martinez-Rodrigo, Arturo
Saz-Lara, Alicia
Pedrosa, João
Otero-Luis, Iris
Moreno-Herraiz, Nerea
Lever-Megina, Carla Geovanna
Martínez-Ortega, Isabel Antonia
Pastor, Jose Manuel
Cavero-Redondo, Iván
Article History
Received: 16 September 2024
Accepted: 18 November 2025
First Online: 5 December 2025
Declarations
:
: The authors declare no Conflict of interest.
: The research protocols for the studies included in this analysis were approved by the Clinical Research Ethics Committee of the Cuenca Health Area, with the following registration numbers: 2022/PI2022 (EVasCu study), 2023/PI1823 (EVasCu 2.0 study), and 2022/PI2122 (ExIC-FEp trial). All the subjects who participated in these studies provided written informed consent. During the development of the study, the standards of the Declaration of Helsinki were accomplished.